Jeil Health Science

Since foundation in 1959, JEIL established central research laboratory for the formulation and synthesis of drugs, followed by successive construction of factory in 1986. JEIL's fine chemical production facilities are entirely controlled by the BGMP according to the GMP guideline for bulk chemical production related to general, special, and aseptic pharmaceuticals. In 2012, JEIL completed dedicated anticancer plant(API,FDF) and Cephalosporin plant(API) according to cGMP standard and obtained GMP approval. We are specialized in developing and producing on patent terminated products to make first generic in exportable countries and also trying to reach the customer's needs with current products. As of November 2016, Jeil Health Science was separated from Jeil Pharmaceutical and became an affiliated company of Jeil Pharmaceutical. Again, as of June 2017, Jeil Pharma Holdings was established in order to govern Jeil Pharmaceutical, Jeil Health Science and Jeil & Partners, focusing on and specializing in its best part so...
Sub-event: FDF18

Contact details

343, Sapyeong-daero
South Korea